MgSO4 vs Metoclopramide for Headache in Pregnant Women

Withdrawn before enrolling · Phase 2/Phase 3

Conditions studied: Headache

In brief

The study will compare effectiveness of intravenous magnesium sulfate to that of intravenous metoclopramide (Reglan®) for acute headache in pregnant women. We will randomize pregnant women who present to our emergency department with chief complaint of headache to magnesium sulfate 2 grams intravenously or metoclopramide 10 mg intravenously; both groups will receive acetaminophen (Tylenol®) 1 gram orally and normal saline 1 liter intravenously. Headaches are common during pregnancy, related to hormonal changes, altered sleep patterns and psychosocial stressors. Common medications for headache such as non-steroidal antiinflammatories or triptans are typically avoided during pregnancy due to concern for fetal effects. Women, and their physicians, are often uncertain regarding available medication options with justifiable safety profiles during pregnancy.

Key facts

Study ID

NCT00632606

Run by

Women and Infants Hospital of Rhode Island

People needed

0

Starts

2008-08-01

Expected to finish

2010-03-01

Last updated by the study team

2012-12-25

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant, 18-75
• Headache rated 4 or greater on a 0-10 pain scale

You may not qualify if…

• New objective neurologic abnormality at the time of exam
• Temperature >100.4
• Allergy or intolerance to study medications
• Suspected of confirmed preeclampsia/eclampsia
• Complete heart block
• Hypotension, SBP<85
• Myasthenia gravis
• End stage renal failure

Where it is running

• Women and Infants Hospital of Rhode Island — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.